Certest Biotec, S.L.
Juan Pablo Martinez Ñañez has a robust background in international business and operations, with significant experience in the coffee export industry as an International Business Coordinator at Cafexcoop S.A. from May 2015 to October 2022, where export plans led to a 20% increase in exports. Prior experience as a Support Operations Assistant at COMEXPAL Customs Agency from September 2013 to September 2014 involved preparing crucial import and export documentation to ensure compliance with customs regulations. Juan Pablo's educational qualifications include a Bachelor's degree in Marketing and International Business from Universidad Autónoma de Occidente, as well as postgraduate degrees in Marketing Management from Centennial College and Project Management from George Brown College, both scheduled for completion in 2024.
This person is not in any teams
This person is not in any offices
Certest Biotec, S.L.
Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious diseases and different markers, covering different needs of formats, types of use, throughput, precision and time from sample to result. VIASURE offers a reliable molecular diagnostic solution, from sample to intepretation of results, covering a wide range portfolio of products and enabling laboratories to better inform clinical decissions. The objective of Certest Pharma is to contribute with its technology to obtain better therapeutic products based on RNA. It is focused on three main áreas: RNAs, Delivery and Vaccines. Additionally, the expertise of our highly qualified personnel, currently numbering over 300 employees, is at the disposal of our customers, offering development and manufacturing services for the production of their own materials.